<div id="readability-page-1">Fast profit exit: Berkshire sold its entire UnitedHealth stake after a 45% rebound from $271 to $394 in nine months. Abel’s portfolio reshaping: New CEO Greg Abel is reducing exposure to sectors with rising downside risks, including healthcare and high-valuation tech. From crisis to recovery: Berkshire bought UnitedHealth during a 2025 collapse triggered by leadership turmoil, regulatory probes, and rising costs.</div>

BRK.A

BRK.B

UNHG

<p>Berkshire Hathaway has sold its entire stake in UnitedHealth, realizing a 45% profit as the stock rebounded from $271 to $394 in nine months. New CEO Greg Abel is reshaping the portfolio by reducing exposure to sectors with rising risks, such as healthcare and high-valuation tech. Berkshire initially invested in UnitedHealth during a crisis in 2025 marked by leadership issues and regulatory challenges.</p>

- Berkshire Hathaway completely divested its UnitedHealth stake after a 45% increase in share price from $271 to $394 within nine months.  
- New CEO Greg Abel is restructuring the portfolio to minimize exposure to sectors with increasing risks, particularly healthcare and high-valuation technology.  
- UnitedHealth was acquired by Berkshire during a crisis in 2025 marked by leadership issues, regulatory investigations, and escalating costs.

Berkshire Hathaway

Berkshire Hathaway B

Unitedhealth

iShares US Healthcare Providers

Leverage Shares 2X Long UNH Daily ETF

VG Health

SPDR S&P Health

iShares Global Healthcare

Health Care Select Sector SPDR

Berkshire Hathaway exits UnitedHealth stake with 45% gain